← Open Payments lookup

LOLITTA AZNAUROVA: Open Payments

NPI 1841270600 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,053 in 115 payments from 18 companies in 2025. Trend: 2023 $1,963 · 2024 $2,045 · 2025 $2,053

Food & beverage: $2,053
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.28$502
ABBVIE INC.23$395
Neurocrine BioSciences, Inc.10$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$115
Lundbeck LLC6$110
Vanda Pharmaceuticals Inc.5$107
Axsome Therapeutics, Inc.6$104
Collegium Pharmaceutical, Inc.5$95
Supernus Pharmaceuticals, Inc.5$93
Janssen Pharmaceuticals, Inc5$85

Products named: VRAYLAR, REXULTI, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, HETLIOZ, ABILIFY MAINTENA, Jornay PM.

Industry payments across KS — which companies pay providers there.